PCN84 CLINICAL AND ECONOMIC OUTCOMES FOR CANCER CHEMOTHERAPY PATIENTS WHEN INITIATED ON ERYTHROPOIESIS-STIMULATING AGENTS (ESA) AT BASELINE (BL) HEMOGLOBIN (HB) I0G/DL
Abstract
Authors
T Burton K Larholt D Hoaglin CL Pashos B Bookhart M Corral RS Mckenzie CT Piech